Davide Verotta

3.2k total citations
91 papers, 2.5k citations indexed

About

Davide Verotta is a scholar working on Statistics and Probability, Pharmacology and Molecular Biology. According to data from OpenAlex, Davide Verotta has authored 91 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Statistics and Probability, 14 papers in Pharmacology and 13 papers in Molecular Biology. Recurrent topics in Davide Verotta's work include Statistical Methods in Clinical Trials (16 papers), Analytical Chemistry and Chromatography (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Davide Verotta is often cited by papers focused on Statistical Methods in Clinical Trials (16 papers), Analytical Chemistry and Chromatography (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Davide Verotta collaborates with scholars based in United States, Italy and Denmark. Davide Verotta's co-authors include Lewis B. Sheiner, Jaap W. Mandema, Chantal Csajka, Karin Fattinger, Janice B. Schwartz, Donald R. Stanski, Neal L. Benowitz, Dong‐Woo Kang, Adam Frymoyer and David R. Drover and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Biometrics and Journal of Applied Physiology.

In The Last Decade

Davide Verotta

91 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davide Verotta United States 27 421 403 355 291 280 91 2.5k
Roberto Goméni Italy 33 582 1.4× 718 1.8× 277 0.8× 381 1.3× 288 1.0× 179 3.3k
David J. Graham United States 33 654 1.6× 867 2.2× 247 0.7× 354 1.2× 369 1.3× 115 5.6k
Oscar Della Pasqua United Kingdom 25 504 1.2× 597 1.5× 230 0.6× 602 2.1× 356 1.3× 159 2.7k
Robert R. Bies United States 32 395 0.9× 736 1.8× 204 0.6× 285 1.0× 328 1.2× 154 3.7k
Samuel Vožeh Switzerland 18 291 0.7× 403 1.0× 214 0.6× 300 1.0× 251 0.9× 28 1.8k
Andrew C. Hooker Sweden 21 559 1.3× 741 1.8× 568 1.6× 531 1.8× 333 1.2× 109 3.8k
Johan Gabrielsson Sweden 29 964 2.3× 397 1.0× 190 0.5× 263 0.9× 523 1.9× 106 3.3k
Iñaki F. Trocóniz Spain 31 756 1.8× 423 1.0× 181 0.5× 263 0.9× 298 1.1× 187 3.6k
Raymond Miller United States 27 221 0.5× 285 0.7× 268 0.8× 608 2.1× 193 0.7× 70 2.8k
Thomas Kerbusch Netherlands 22 411 1.0× 239 0.6× 165 0.5× 239 0.8× 359 1.3× 47 1.9k

Countries citing papers authored by Davide Verotta

Since Specialization
Citations

This map shows the geographic impact of Davide Verotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Verotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Verotta more than expected).

Fields of papers citing papers by Davide Verotta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Verotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Verotta. The network helps show where Davide Verotta may publish in the future.

Co-authorship network of co-authors of Davide Verotta

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Verotta. A scholar is included among the top collaborators of Davide Verotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Verotta. Davide Verotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Liusheng, Janus A. J. Haagensen, Davide Verotta, et al.. (2018). Determination of Tobramycin in M9 Medium by LC-MS/MS: Signal Enhancement by Trichloroacetic Acid. Journal of Analytical Methods in Chemistry. 2018. 1–8. 8 indexed citations
2.
Haagensen, Janus A. J., Davide Verotta, Liusheng Huang, et al.. (2017). Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms. Journal of Antimicrobial Chemotherapy. 72(12). 3357–3365. 23 indexed citations
3.
Dong, Betty J., Yu Zheng, Michael D. Hughes, et al.. (2012). Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women. AIDS. 26(7). 833–841. 26 indexed citations
4.
Kang, Dong Hee, Davide Verotta, & Joseph E. Schwartz. (2006). Population analyses of amlodipine in patients living in the community and patients living in nursing homes. Clinical Pharmacology & Therapeutics. 79(1). 114–124. 18 indexed citations
5.
Kshirsagar, Smita, et al.. (2006). Improving Data Reliability Using a Non-Compliance Detection Method versus Using Pharmacokinetic Criteria. Journal of Pharmacokinetics and Pharmacodynamics. 34(1). 35–55. 5 indexed citations
6.
7.
Verotta, Davide. (2005). Models and estimation methods for clinical HIV-1 data. Journal of Computational and Applied Mathematics. 184(1). 275–300. 11 indexed citations
8.
Kang, Dong‐Woo, Janice B. Schwartz, & Davide Verotta. (2005). Sample Size Computations for PK/PD Population Models. Journal of Pharmacokinetics and Pharmacodynamics. 32(5-6). 685–701. 31 indexed citations
9.
Kang, Dong‐Woo, Janice B. Schwartz, & Davide Verotta. (2004). A sample size computation method for non‐linear mixed effects models with applications to pharmacokinetics models. Statistics in Medicine. 23(16). 2551–2566. 25 indexed citations
10.
Verotta, Davide. (2003). Volterra Series in Pharmacokinetics and Pharmacodynamics. Journal of Pharmacokinetics and Pharmacodynamics. 30(5). 337–362. 2 indexed citations
11.
Benowitz, Neal L., et al.. (2002). Modeling Nicotine Arterial–Venous Differences to Predict Arterial Concentrations and Input Based on Venous Measurements: Application to Smokeless Tobacco and Nicotine Gum. Journal of Pharmacokinetics and Pharmacodynamics. 29(4). 383–402. 14 indexed citations
12.
Kindler, Christoph, Davide Verotta, Andrew T. Gray, Michael A. Gropper, & C. Spencer Yost. (2000). Additive Inhibition of Nicotinic Acetylcholine Receptors by Corticosteroids and the Neuromuscular Blocking Drug Vecuronium. Anesthesiology. 92(3). 821–832. 35 indexed citations
13.
Park, Kyungsoo, Davide Verotta, Suneel Gupta, & Lewis B. Sheiner. (1998). Use of a Pharmacokinetic/Pharmacodynamic Model to Design an Optimal Dose Input Profile. Journal of Pharmacokinetics and Biopharmaceutics. 26(4). 471–492. 18 indexed citations
14.
Benowitz, Neal L., et al.. (1998). Importance of Chronopharmacokinetics in Design and Evaluation of Transdermal Drug Delivery Systems. Journal of Pharmacology and Experimental Therapeutics. 285(2). 457–463. 16 indexed citations
15.
Trocóniz, Iñaki F., et al.. (1997). A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complex*. Clinical Pharmacology & Therapeutics. 61(1). 70–82. 10 indexed citations
16.
Benowitz, Neal L., et al.. (1996). Chronopharmacokinetics of nicotine*. Clinical Pharmacology & Therapeutics. 60(4). 385–395. 39 indexed citations
17.
Verotta, Davide & Lewis B. Sheiner. (1995). A general conceptual model for non-steady state pharmacokinetic/Pharmacodynamic data. Journal of Pharmacokinetics and Biopharmaceutics. 23(1). 1–4. 35 indexed citations
18.
Schwartz, Janice B., et al.. (1993). Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil.. Journal of Pharmacology and Experimental Therapeutics. 265(2). 690–698. 24 indexed citations
19.
Verotta, Davide & Lewis B. Sheiner. (1991). Semiparametric analysis of non-steady-state pharmacodynamic data. Journal of Pharmacokinetics and Biopharmaceutics. 19(6). 691–712. 24 indexed citations
20.
Boyd, Rebecca A., et al.. (1989). The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose. Clinical Pharmacology & Therapeutics. 46(4). 408–419. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Goméni Breakdown of academic impact, for papers by David J. Graham Breakdown of academic impact, for papers by Oscar Della Pasqua Breakdown of academic impact, for papers by Robert R. Bies Breakdown of academic impact, for papers by Samuel Vožeh Breakdown of academic impact, for papers by Andrew C. Hooker Breakdown of academic impact, for papers by Johan Gabrielsson Breakdown of academic impact, for papers by Iñaki F. Trocóniz Breakdown of academic impact, for papers by Raymond Miller Breakdown of academic impact, for papers by Thomas Kerbusch
Rankless by CCL
2026